Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias

Q: What does this research mean for the field?

Depletion of CD8+ CAR T-cells and the use of pure CD4+ CAR T-cells leads to superior anti-tumor efficacy against acute leukemias. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Qian Chen (18883); David Sedloev; Hao Yao; Lianghao Mao; Dominic Depke; Lei Wang (6656); Marina Scheller; Bailin He; Yi Liu (36759); Julia M. Unglaub; A Schmitt; Ashok Kumar Jayavelu; Carsten Müller tidow; Michael Schmitt; Tim Sauer

doi:10.1016/j.ymthe.2026.05.027

June 1, 2026Molecular TherapyOpen Access

Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to explore how the depletion of CD8+ CAR T-cells affects the effectiveness of CD4+ CAR T-cells in treating acute leukemias.
Evaluated CAR T-cell compositions in preclinical models.
Assessed anti-tumor responses in acute leukemia contexts.
Analyzed therapeutic persistence and durability of treatment effects.
CD4+ CAR T-cells showed improved anti-tumor efficacy following CD8+ CAR T-cell depletion.
Increased persistence of CD4+ CAR T-cells in the tumor microenvironment was observed.
The findings support a potential new approach to enhancing leukemia treatment outcomes.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Demonstrates enhanced anti-tumor efficacy of CD4+ CAR T-cells in acute leukemias, suggesting a new therapeutic strategy.

Abstract

CART efficacy and provide a framework for optimizing CART product composition to enhance therapeutic persistence and durability.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

(18883) et al. (2026) studied this question.

synapsesocial.com/papers/6a23b8f271a5da9775e74f26 https://doi.org/10.1016/j.ymthe.2026.05.027

View Full Paper

Ask AI

Bookmark

Share

Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading